AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…
168,440€
1,79%
Echtzeit-Aktienkurs Abbvie Inc.
Bid:
Ask:
Nachrichten zur Abbvie Inc. Aktie
Allergan Aesthetics Says FDA Approves SKINVIVE By JUVEDERM
WASHINGTON (dpa-AFX) - Allergan Aesthetics, an AbbVie company (ABBV), announced Monday the U.S. FDA approval of SKINVIVE by JUVEDERM to…
AbbVie Says Health Canada Approves RINVOQ To Treat Adults With Active Nr-axSpA
OTTAWA (dpa-AFX) - AbbVie (ABBV) announced Tuesday that Health Canada has approved RINVOQ (upadacitinib, 15 mg), the first oral, once-daily…
AbbVie Rinvoq gets approval in Canada for expanded use in axial spondyloarthritis
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Looking for Steady, Passive Income? Buy AbbVie Stock
The drugmaker looks poised to rebound from its Humira loss of exclusivity....…
Form 10-Q AbbVie Inc. For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
2 Things About AbbVie That Investors Are Ignoring
AbbVie shares slipped following the latest earnings report....…
Vertex Pharmaceuticals Stock Is an Even Better Buy Now Thanks to AbbVie
One big drugmakers pain translates into another big drugmakers gain....…
AbbVie, Bristol Myers Vied for Prometheus Before Merck Bought It
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Where Will AbbVie Be in 5 Years?
AbbVie has been a strong performer since its split from Abbott Labs, and its trying hard to keep the momentum…
AbbVie Stock Plunged: Should You Buy the Dip?
Last weeks sell-off appears to have been overdone....…
Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie (ABBV) Q1 2023 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2023....…
Insiderhandel: SVP, US COMMERCIAL OPERATIONS verkauft Aktien von AbbVie im Wert von 1.011.450$
Sorg, Elaine K. - Vorstand - Tag der Transaktion: 2023-04-25...…
Why did AbbVie stock fall today? Lower than expected EPS, sales
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Why AbbVie Stock Is Crashing Today
AbbVies 2023 Q1 report isnt sitting well with shareholders today....…
AbbVie (ABBV) Q1 Earnings Beat, Skyrizi Sales Underperform
AbbVies (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates....…
AbbVie Stock Falls as Humira Sales Drop
First-quarter sales for the anti-inflammatory drug fell 25% from a year ago on a reported basis....…
Vertex gains as AbbVie ends cystic fibrosis development program
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie: Enttäuschend in das neue Jahr - Aktienanalyse
Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG:
Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…
AbbVie (ABBV) Q1 Earnings and Revenues Top Estimates
AbbVie (ABBV) delivered earnings and revenue surprises of 0.82% and 1.17%, respectively, for the quarter ended March 2023. Do the…
AbbVie Q1 Profit Drops, Inline With Estimates
WASHINGTON (dpa-AFX) - AbbVie (ABBV) reported earnings for first quarter that decreased from last year in line with the Street…
AbbVie falls as key drugs underperform amid Humira patent cliff
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie stock falls toward a 6-week low after adjusted profit fell short of expectations, but the full-year outlook was raised
Shares of AbbVie Inc. ABBV dove 6.2% toward a six-week low in premarket trading Thursday, after the biopharmaceutical company missed…
AbbVie stock sinks 5.1% premarket after Q1 profit missed expectations
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
AbbVie raises as Humira demand holds steady
...(Reuters) - AbbVie Inc on Thursday raised its 2023 profit......…
AbbVie Reports First-Quarter 2023 Financial Results
Reports First-Quarter Diluted EPS of $0.13 on a GAAP Basis, a Decrease of 94.8 Percent; Adjusted Diluted EPS of $2.46,…
AbbVie Non-GAAP EPS of $2.46 misses by $0.03, revenue of $12.23B in-line
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Will Humira competition impact AbbVie Q1 results?
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Previews: AbbVie, Altria, American Airlines, Merck
Two pharmaceutical giants, one a Dow component, report quarterly results before markets open on Thursday. A major airline and a…
AbbVie Stock Holds Support and Gives Traders a Buying Opportunity
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: SVP, US COMMERCIAL OPERATIONS verkauft Aktien von AbbVie im Wert von 1.212.338$
Sorg, Elaine K. - Vorstand - Tag der Transaktion: 2023-04-17...…
3 Reasons Why I Regret Selling AbbVie
Having the knowledge to stay steady in your convictions can be a game changer....…
The Zacks Analyst Blog Highlights JPMorgan Chase, AbbVie, NextEra Energy, The Boeing and Canadian Natural Resources
JPMorgan Chase, AbbVie, NextEra Energy, The Boeing and Canadian Natural Resources are part of the Zacks top Analyst Blog....…
Top Research Reports for JPMorgan Chase, AbbVie & NextEra Energy
Todays Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV)…
Why AbbVie (ABBV) Could Beat Earnings Estimates Again
AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Why 2023 Could Be a Tough Year for AbbVie Stock
Should you buy the stock despite its headwinds?...…
Übernahme von Botox-Hersteller gibt AbbVie Schub
Frankfurt (Reuters) - Der US-Pharmakonzern AbbVie profitiert von einer hohen Nachfrage nach seinem Blockbuster-Medikament Humira und der Übernahme des Botox-Herstellers…
Agentur - Boehringer und AbbVie in Gesprächen über Krebs-Allianz
Bangalore (Reuters) - Deutschlands zweitgrößter Pharmakonzern Boehringer Ingelheim steht einem Agenturbericht zufolge vor einer umfassenden Partnerschaft bei Krebs-Therapien mit dem…